World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
30806
World Ranking
10916
National Ranking
5615

Overview

Wayne L. Hofstetter is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medical disciplines, with a strong emphasis on pulmonary and respiratory medicine, surgery, and oncology. Additional expertise lies in molecular biology and radiology, nuclear medicine, and imaging.

Themes central to Hofstetter's work include esophageal cancer research and treatment, gastric cancer management and outcomes, as well as lung cancer diagnosis and treatment. Their publications also cover esophageal and gastrointestinal pathology, lung cancer treatments and mutations, cancer immunotherapy and biomarkers, and pleural and pulmonary diseases.

Hofstetter has contributed extensively to scientific literature, particularly in clinical and surgical oncology. Frequent publication venues for their work include:

  • Journal of Thoracic and Cardiovascular Surgery
  • The Annals of Thoracic Surgery
  • Journal of Surgical Oncology
  • Diseases of the Esophagus
  • Journal of Clinical Oncology

Several coauthors frequently collaborate with Hofstetter, including:

  • David C. Rice
  • Ara A. Vaporciyan
  • Reza J. Mehran
  • Stephen G. Swisher
  • Boris Sepesi

Highlighted recent publications authored or coauthored by Hofstetter include:

  • Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network
  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial, 2021, Nature Medicine
  • Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology, 2023, Journal of the National Comprehensive Cancer Network
  • Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline, 2020, Journal of Clinical Oncology
  • Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer, 2020, Journal of Clinical Oncology

Best Publications

  • International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG)

    Donald E. Low;Derek Alderson;Ivan Cecconello;Andrew C. Chang

  • Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

    Jaffer A. Ajani;Thomas A. D'Amico;Khaldoun Almhanna;David J. Bentrem

  • Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

    Jaffer A. Ajani;Thomas A. D'Amico;David J. Bentrem;Joseph Chao

  • Benchmarking Complications Associated with Esophagectomy.

    Donald E. Low;Madhan Kumar Kuppusamy;Derek Alderson;Ivan Cecconello

  • Gastric Cancer, Version 2.2013

    Jaffer A. Ajani;David J. Bentrem;Stephen Besh;Thomas A. D'Amico

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

    Tina Cascone;William N. William;Annikka Weissferdt;Cheuk H. Leung

  • Optimum lymphadenectomy for esophageal cancer.

    Nabil P. Rizk;Hemant Ishwaran;Thomas W. Rice;Long Qi Chen

  • Esophageal and esophagogastric junction cancers, version 1.2015.

    Jaffer A. Ajani;Thomas A. D'Amico;Khaldoun Almhanna;David J. Bentrem

  • Treatment Outcomes of Resected Esophageal Cancer

    Wayne Hofstetter;Stephen G. Swisher;Arlene M. Correa;Kenneth Hess

  • Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial

    Charles S. Cleeland;Xin Shelley Wang;Qiuling Shi;Tito R. Mendoza

  • Esophageal and Esophagogastric Junction Cancers

    Jaffer A. Ajani;James S. Barthel;David J. Bentrem;Thomas A. D'Amico

  • Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer

    Steven Hsesheng Lin;Lu Wang;Bevan Myles;Peter F Thall

  • Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

    T. W. Rice;H. Ishwaran;W. L. Hofstetter;D. P. Kelsen

  • Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

    Thomas W. Rice;Donna M. Gress;Deepa T. Patil;Wayne L. Hofstetter

  • Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis

    Nirav Thosani;Harvinder Singh;Asha Kapadia;Nobuo Ochi

  • Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.

    Kim L. Wang;Tsung-Teh Wu;In Seon Choi;Huamin Wang

  • Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

    David C. Rice;Craig W. Stevens;Arlene M. Correa;Ara A. Vaporciyan

  • Hippo coactivator YAP1 upregulates SOX9 and endows esophageal Cancer cells with stem-like properties

    Shumei Song;Jaffer A Ajani;Soichiro Honjo;Dipen Maheshbhai Maru

  • Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.

    Lixia Liu;Wayne L. Hofstetter;Asif Rashid;Stephen G. Swisher

  • The hippo coactivator YAP1 mediates EGFR overexpression and confers chemoresistance in esophageal cancer

    Shumei Song;Soichiro Honjo;Jiankang Jin;Shih Shin Chang

Frequent Co-Authors

Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
David C. Rice
David C. Rice The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Ara A. Vaporciyan
Ara A. Vaporciyan The University of Texas MD Anderson Cancer Center
Garrett L. Walsh
Garrett L. Walsh The University of Texas MD Anderson Cancer Center
Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Zhongxing Liao
Zhongxing Liao The University of Texas MD Anderson Cancer Center
Xuemei Wang
Xuemei Wang The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if medical school is the only option? There are a variety of online degrees and pathways in the health field that can lead to rewarding careers, many of which have flexible entry requirements and shorter study times.

Becoming a Registered Nurse is one of the most popular alternatives. For those looking for an accessible path, check out some of the easiest rn program to get into. Some nursing schools are also more accessible because they are nursing schools that don't require teas test, making them an excellent choice if you’re concerned about entrance exams.

If administration interests you, explore fully online healthcare administration degrees that can prepare you for leadership and management roles. Alternatively, consider a specialized field such as medical billing and coding, where you might qualify for financial aid for medical billing and coding online classes.

These alternative pathways offer the flexibility and accessibility many students seek, helping you start a health-focused career in less time and often at a lower cost.

Best Scientists Citing Wayne L. Hofstetter

Trending Scientists

Recently Published Articles